2013 annual financial data
Neuphoria Therapeutics 2013 Operating cash flow margin
Direct answer
Operating cash flow margin was -418.04%.
Operating income was -18,266,501 USD and net income was -9,127,234 USD.
Operating cash flow was -10,439,193 USD.
Get free Neuphoria Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,497,197 USD
- Operating income
- -18,266,501 USD
- Net income
- -9,127,234 USD
- Operating cash flow
- -10,439,193 USD